Stories
Almost every new ground-breaking cancer treatment has been a result of clinical trials research. ANZUP works towards improving treatments and outcomes by undertaking clinical trials in below the belt (prostate, bladder, kidney, penile and testicular) cancer. These trials and research allows us to test better ways of helping people.
Some of our community have generously shared their experiences with cancer, clinical trials and fundraising. Here you can read about what we do, why we do it, why these cancers need to be talked about and why clinical trials are so important.
And if you have a story you would like to share, contact us at anzup@anzup.org.au
Lost in clinical trial language?
Have you ever read a cancer research update and felt like you needed a medical dictionary to understand it? You’re not alone. …
Interim findings from the DASL-HiCaP trial (ANZUP 1801), jointly led by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group …
DASL-HiCaP: Q&A with our CEO Prof Sam Oakes
In a nutshell, can you tell us about the trial? DASL-HiCaP is a major international phase 3 clinical trial co-led by …
DASL-HiCaP explained: New treatment approach offers hope for people with very high-risk prostate cancer
An Australian-led international clinical trial has found that adding darolutamide to standard treatment can help people with very high-risk localised or locally …
Ally Morrice Urology Oncology Clinical Nurse At ANZUP, we believe better cancer care starts with collaboration. Our multidisciplinary network brings together researchers, …
Can I trust a clinical trial?
If you or someone you love has cancer, the idea of taking part in a clinical trial can bring up a lot …
Carers: the people behind the diagnosis
When someone is diagnosed with a below the belt cancer including prostate, bladder, kidney, testicular or penile cancer the impact reaches beyond …
Enzalutamide: looking at the benefits and the cost
The ENZAMET trial has shown that adding enzalutamide to hormone therapy can help people with metastatic hormone-sensitive prostate cancer live longer and …
The latest results from the international ENZAMET clinical trial provide encouraging evidence that enzalutamide can help people with metastatic hormone-sensitive prostate cancer …
Everything you need to know about clinical trials
Have you ever seen the words ‘clinical trial’ and wondered what they actually mean? If you or someone you love has been …
More Australians are living with cancer so what does this mean for below the belt cancers?
More Australians are expected to be living with or beyond cancer in the coming decades. New research published in The Lancet Regional …
Palliative Care: More Than End-of-Life Care
Receiving a diagnosis of a life-limiting condition, such as advanced cancer, can be overwhelming, but help is available. Palliative care is specialised …
Being diagnosed with a genitourinary (GU), or below-the-belt, cancer such as prostate, bladder, kidney, testicular or penile cancer can feel overwhelming. Knowing …
I’ve been diagnosed with a Below the Belt Cancer. Could a Clinical Trial be right for me?
A diagnosis of genitourinary (GU) cancer, such as prostate, kidney, bladder, testicular or penile cancer, can raise many questions about the treatment …
Prostate cancer: what’s changed in 10 years?
Prostate cancer detection and care have changed significantly over the past decade. New Australian guidelines, approved by the National Health and Medical …
At ANZUP, research is about more than treatments, trials and scientific discoveries. It’s about people. Every day, we see patients and families …
Why haven’t we cured cancer yet?
Every year on World Cancer Day (4 February), people around the world pause to reflect on the impact of cancer, honour those …
Q&A: Tim Weale’s journey with prostate cancer
Interviewer: Can you please tell me a little bit about your cancer journey? How old were you at the time of diagnosis, …
Juliet De Nittis was told she had less than a year to live. Today – nearly seven years later, she’s cancer free and embracing a life …
Jack Taylor was just 20 years old when he noticed blood in his urine. A month later, he was diagnosed with high-risk …